SEC Form 4 · accession 0001209191-16-119601
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip G. Febbo
Officer — Chief Medical Officer
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4 | May 10, 2016 | S | 6,224 | $27.1885 | D | 15,113 | D | |
| Common StockF1,F5,F4 | May 10, 2016 | S | 100 | $28.13 | D | 15,013 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 9, 2016.
- F2Represents weighted average sale price. Actual sale prices ranged from $26.56 to $27.55.
- F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F4Includes an aggregate of 13,948 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F5Represents actual sale price.